Cigna
776 hedge funds and large institutions have $37.6B invested in Cigna in 2017 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 253 increasing their positions, 285 reducing their positions, and 46 closing their positions.
295% more call options, than puts
Call options by funds: $495M | Put options by funds: $125M
52% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 46
14% more capital invested
Capital invested by funds: $33B → $37.6B (+$4.62B)
8% more funds holding in top 10
Funds holding in top 10: 13 → 14 (+1)
3% more funds holding
Funds holding: 756 → 776 (+20)
0.07% more ownership
Funds ownership: 87.74% → 87.8% (+0.07%)
11% less repeat investments, than reductions
Existing positions increased: 253 | Existing positions reduced: 285
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$266M |
| 2 |
O
OrbiMed
New York
|
+$196M |
| 3 |
JP Morgan Chase
New York
|
+$190M |
| 4 |
Morgan Stanley
New York
|
+$184M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$72.2M |
Top Sellers
CI Hedge Fund Activity: Q2 2017 in Review
776 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cigna (CI) for Q2 2017, worth a combined $37.6B — up 14% from $33B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new CI positions and 46 closed out — a net gain of 24 holders — while 253 added to existing stakes and 285 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $266M. The largest seller was Glenview Capital Management, cutting an estimated $187M.
- 776 institutional investors held Cigna (CI) as of Q2 2017, up from 756 in Q1 2017.
- Funds reported $37.6B of Cigna stock for Q2 2017, up 14% quarter-over-quarter.
- 70 funds opened new Cigna positions in Q2 2017 and 46 closed out, a net change of +24 holders.
- The largest Cigna buyer in Q2 2017 was T. Rowe Price Associates, an estimated $266M added.
- The largest Cigna seller in Q2 2017 was Glenview Capital Management, an estimated $187M sold.
Based on aggregated 13F filings for Q2 2017.